ROS-cleavable Diselenide Nanomedicine for NIR-controlled Drug Release and On-Demand Synergistic Chemo-Photodynamic Therapy.

Ren Zhu,Qi He,Zhiling Li,Yuhao Ren,Yixian Liao,Zejun Zhang,Quan Dai,Chengying Wan,Sihui Long,Lingyi Kong,Wenpei Fan,Wenying Yu
DOI: https://doi.org/10.1016/j.actbio.2022.09.061
IF: 10.633
2022-01-01
Acta Biomaterialia
Abstract:Many chemotherapeutic drugs and photosensitizers suffer from poor solubility, unspecific delivery and uncontrollable release, which severely impede their biomedical applications. Herein, we designed a type of ROS-cleavable hydrophilic diselenide nanoparticles through self-assembling of PEG-modified camptothecin (CPT, a hydrophobic drug) and meso-tetra (4-carboxyphenyl) porphine (TCPP, a hydrophobic photosensitizer). The TCPP@SeSe-CPT nanomedicine (particle size: 116.5 +/- 1.9 nm) has stability for long-time blood circulation. Near-infrared (NIR) laser-triggered generation of ROS from TCPP can efficiently break the ROS-sensitive diselenide bond, which induces the decomposition of TCPP@SeSe-CPT nanomedicine for concurrent release of CPT and TCPP. Moreover, the released amounts of CPT and TCPP can be regulated by adjusting the NIR laser irradiation time. Such NIR-controlled release of CPT and TCPP can give rise to on-demand synergistic chemo-/photodynamic therapeutic effects for maximized tumor growth suppression with minimized side effects.
What problem does this paper attempt to address?